Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth L Berkow

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Antimicrobial Agents and Chemotherapy|September 5, 2019
<i>In Vitro</i> Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with <i>FKS</i> MutationsNatalie S Nunnally, Kizee A Etienne, David Angulo, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2021
Antifungal activity of nikkomycin Z against Candida aurisMeghan L Bentz, Natalie Nunnally, Shawn R Lockhart, et al.
Microbiology Spectrum|January 11, 2023
<i>In Vitro</i> Activity of the Novel Antifungal Olorofim against <i>Scedosporium</i> and <i>Lomentospora prolificans</i>Ourania Georgacopoulos, Natalie Nunnally, Derek Law, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Pharmacodynamic Optimization for Treatment of Invasive Candida auris InfectionAlexander J Lepak, Miao Zhao, Elizabeth L Berkow, et al.
Medical Mycology|February 5, 2019
Erratum: Candida auris: The recent emergence of a multidrug-resistant fungal PathogenKaitlin Forsberg, Kate Woodworth, Maroya Walters, et al.
Medical Mycology|August 8, 2018
Candida auris: The recent emergence of a multidrug-resistant fungal pathogenKaitlin Forsberg, Kate Woodworth, Maroya Walters, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Detection of TR<sub>34</sub>/L98H <i>CYP51A</i> Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017Elizabeth L Berkow, Natalie S Nunnally, Alex Bandea, et al.
Eukaryotic Cell|March 25, 2014
UPC2 is universally essential for azole antifungal resistance in Candida albicansErin M Vasicek, Elizabeth L Berkow, Stephanie A Flowers, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USASteven F Hurst, Elizabeth L Berkow, Katherine L Stevenson, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2022
Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole ResistanceLaura A Doorley, Jeffrey M Rybak, Elizabeth L Berkow, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Antimicrobial Agents and Chemotherapy|September 5, 2019
<i>In Vitro</i> Activity of Ibrexafungerp, a Novel Glucan Synthase Inhibitor against Candida glabrata Isolates with <i>FKS</i> MutationsNatalie S Nunnally, Kizee A Etienne, David Angulo, et al.
The Journal of Antimicrobial Chemotherapy|March 7, 2021
Antifungal activity of nikkomycin Z against Candida aurisMeghan L Bentz, Natalie Nunnally, Shawn R Lockhart, et al.
Microbiology Spectrum|January 11, 2023
<i>In Vitro</i> Activity of the Novel Antifungal Olorofim against <i>Scedosporium</i> and <i>Lomentospora prolificans</i>Ourania Georgacopoulos, Natalie Nunnally, Derek Law, et al.
Antimicrobial Agents and Chemotherapy|June 7, 2017
Pharmacodynamic Optimization for Treatment of Invasive Candida auris InfectionAlexander J Lepak, Miao Zhao, Elizabeth L Berkow, et al.
Medical Mycology|February 5, 2019
Erratum: Candida auris: The recent emergence of a multidrug-resistant fungal PathogenKaitlin Forsberg, Kate Woodworth, Maroya Walters, et al.
Medical Mycology|August 8, 2018
Candida auris: The recent emergence of a multidrug-resistant fungal pathogenKaitlin Forsberg, Kate Woodworth, Maroya Walters, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2018
Detection of TR<sub>34</sub>/L98H <i>CYP51A</i> Mutation through Passive Surveillance for Azole-Resistant Aspergillus fumigatus in the United States from 2015 to 2017Elizabeth L Berkow, Natalie S Nunnally, Alex Bandea, et al.
Eukaryotic Cell|March 25, 2014
UPC2 is universally essential for azole antifungal resistance in Candida albicansErin M Vasicek, Elizabeth L Berkow, Stephanie A Flowers, et al.
The Journal of Antimicrobial Chemotherapy|June 3, 2017
Isolation of azole-resistant Aspergillus fumigatus from the environment in the south-eastern USASteven F Hurst, Elizabeth L Berkow, Katherine L Stevenson, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2022
Candida parapsilosis Mdr1B and Cdr1B Are Drivers of Mrr1-Mediated Clinical Fluconazole ResistanceLaura A Doorley, Jeffrey M Rybak, Elizabeth L Berkow, et al.
Pageof 6